Cargando…
Excess deaths in the United States during the first year of COVID-19
Accurately determining the number of excess deaths caused by the COVID-19 pandemic is hard. The most important challenge is determining the counterfactual count of baseline deaths that would have occurred in its absence. Flexible estimation methods were used here to provide this baseline number and...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304075/ https://www.ncbi.nlm.nih.gov/pubmed/35878708 http://dx.doi.org/10.1016/j.ypmed.2022.107174 |
_version_ | 1784752019660079104 |
---|---|
author | Ruhm, Christopher J. |
author_facet | Ruhm, Christopher J. |
author_sort | Ruhm, Christopher J. |
collection | PubMed |
description | Accurately determining the number of excess deaths caused by the COVID-19 pandemic is hard. The most important challenge is determining the counterfactual count of baseline deaths that would have occurred in its absence. Flexible estimation methods were used here to provide this baseline number and plausibility of the resulting estimates was evaluated by examining how changes between baseline and actual prior year deaths compared to historical year-over-year changes during the previous decade. Similar comparisons were used to examine the reasonableness of excess death estimates obtained in prior research. Total, group-specific and cause-specific excess deaths in the U.S. from March 2020 through February 2021 were calculated using publicly available data covering all deaths from March 2009 through December 2020 and provisional data for January 2021 and February 2021. The estimates indicate that there were 649,411 (95% CI: 600,133 to 698,689) excess deaths in the U.S. from 3/20–2/21, a 23% (95% CI: 21%–25%) increase over baseline, with 82.9% (95% CI: 77.0% - 89.7%) of these attributed directly to COVID-19. There were substantial differences across population groups and causes in the ratio of actual-to-baseline deaths, and in the contribution of COVID-19 to excess mortality. Prior research has probably often underestimated baseline mortality and so overstated both excess deaths and the percentage of them attributed to non-COVID-19 causes. |
format | Online Article Text |
id | pubmed-9304075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93040752022-07-22 Excess deaths in the United States during the first year of COVID-19 Ruhm, Christopher J. Prev Med Article Accurately determining the number of excess deaths caused by the COVID-19 pandemic is hard. The most important challenge is determining the counterfactual count of baseline deaths that would have occurred in its absence. Flexible estimation methods were used here to provide this baseline number and plausibility of the resulting estimates was evaluated by examining how changes between baseline and actual prior year deaths compared to historical year-over-year changes during the previous decade. Similar comparisons were used to examine the reasonableness of excess death estimates obtained in prior research. Total, group-specific and cause-specific excess deaths in the U.S. from March 2020 through February 2021 were calculated using publicly available data covering all deaths from March 2009 through December 2020 and provisional data for January 2021 and February 2021. The estimates indicate that there were 649,411 (95% CI: 600,133 to 698,689) excess deaths in the U.S. from 3/20–2/21, a 23% (95% CI: 21%–25%) increase over baseline, with 82.9% (95% CI: 77.0% - 89.7%) of these attributed directly to COVID-19. There were substantial differences across population groups and causes in the ratio of actual-to-baseline deaths, and in the contribution of COVID-19 to excess mortality. Prior research has probably often underestimated baseline mortality and so overstated both excess deaths and the percentage of them attributed to non-COVID-19 causes. Elsevier Inc. 2022-09 2022-07-22 /pmc/articles/PMC9304075/ /pubmed/35878708 http://dx.doi.org/10.1016/j.ypmed.2022.107174 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ruhm, Christopher J. Excess deaths in the United States during the first year of COVID-19 |
title | Excess deaths in the United States during the first year of COVID-19 |
title_full | Excess deaths in the United States during the first year of COVID-19 |
title_fullStr | Excess deaths in the United States during the first year of COVID-19 |
title_full_unstemmed | Excess deaths in the United States during the first year of COVID-19 |
title_short | Excess deaths in the United States during the first year of COVID-19 |
title_sort | excess deaths in the united states during the first year of covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304075/ https://www.ncbi.nlm.nih.gov/pubmed/35878708 http://dx.doi.org/10.1016/j.ypmed.2022.107174 |
work_keys_str_mv | AT ruhmchristopherj excessdeathsintheunitedstatesduringthefirstyearofcovid19 |